Arena Pharma (ARNA) Tops Q3 EPS by 2c

November 7, 2016 4:34 PM EST
Get Alerts ARNA Hot Sheet
Trade ARNA Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $19 million versus the consensus estimate of $13.99 million.

For earnings history and earnings-related data on Arena Pharma (ARNA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment